Alumis (NASDAQ:ALMS) Trading Down 9.6% - Should You Sell?

Alumis Inc. (NASDAQ:ALMS) shares dropped 9.6% to $24.89 during mid-day trading on Tuesday, with significantly reduced trading volume. This comes after the clinical-stage biopharmaceutical company missed quarterly earnings expectations and saw insiders sell shares, despite generally positive analyst ratings and new institutional investments from firms like BlackRock. The company maintains a "Moderate Buy" consensus from analysts with an average price target of $40.30.